Archives: Agenda

• Maximize the value of existing patient involvement efforts by “translating” patient advisory board insights into participant-facing materials
• Meet growing regulatory expectations for patient involvement in participant materials development
• Implement a co-development approach with patients and advisors review
• Internal planning tips for timelines, stakeholder engagement, and IRB submission strategies
• Best practices in health literacy to ensure clarity, trust, and accessibility

• Exploring how building authentic relationships with patients and local healthcare providers create meaningful opportunities for research participation
• Sharing how consistent engagement, education, and community-first strategies foster trust and drive better outcomes in clinical trials through real-world stories and examples from local outreach events.
• Insights into how inclusive outreach expands trial access, strengthens provider partnerships, and delivers measurable impact for both patients and sponsors

Consistent patient engagement is vital to clinical trial success, yet dropout and non-compliance remain persistent challenges. This session introduces gamification as a scientifically grounded strategy to boost retention, enhance adherence, and streamline trial execution.

• Understand the Science: Explore the behavioral and psychological foundations that make gamification a powerful tool for sustaining patient motivation
• See Real Results: Review real-world case studies where gamification significantly improved retention, compliance, and trial timelines
• Apply Proven Methods: Learn practical strategies and best practices for integrating gamified elements into clinical trial protocols

• Navigating the evolving VC landscape and investor expectations
• Leveraging funding options such as grants, strategic partnerships and government programs
• Building strong enough data to convince investors while managing with limited capital

• We’ll discuss findings from a recent study on site and patient perspectives on Direct-to-Patient shipments of investigational product.
• Explore feasibility across different treatment types, and what investigative sites see as the key benefits and drawbacks.
• Learn how shipping models like site-to-patient (STP) and warehouse-to-patient (WTP) are perceived by sites and how these influence enrollment speed, study start-up, and close-out.
• Understand how patients perceive direct-to-patient shipments, what has worked well and where common challenges arise from the patient’s perspective.

• Weighing up pros and cons of FSP vs other outsourcing models: is FSP right for your clinical trial?
• Defining the FSP model and understanding when it is the right fit for your organization
• Selecting the right FSP partners to complement internal capabilities
• Optimizing cost efficiency and scalability through flexible FSP partnerships

MODERATOR John Seman, Chief Executive Officer, Revitale Pharma